Yield10 Bioscience to Present at Maxim Group’s 2021 Inaugural Emerging Growth Virtual Conference

Rhea-AI Summary

Yield10 Bioscience, an agricultural bioscience company, announced that CEO Oliver Peoples will present at Maxim Group’s 2021 Inaugural Emerging Growth Virtual Conference from March 17-19, 2021. Investors can register to view the presentation and request one-on-one meetings with management. Yield10 specializes in developing improved Camelina varieties and discovering valuable genetic traits for agriculture. The company aims to create a high-value seed products business targeting feedstock oils and bioplastics, with a focus on major crops like corn and soybean.

WOBURN, Mass., March 11, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announces that Chief Executive Officer Oliver Peoples, PhD. will present at Maxim Group’s 2021 Inaugural Emerging Growth Virtual Conference to be held March 17-19, 2021.

Investors can view the Yield10 corporate presentation made by Dr. Peoples once they register for the conference here, and an archived replay of the presentation will be available via the conference website. Investors can also request a 1x1 meeting with management of Yield10 which will be arranged following the conclusion of the virtual conference event.

About Yield10 Bioscience

Yield10 Bioscience, Inc. is an agricultural bioscience company that is using its differentiated trait gene discovery platform, the “Trait Factory”, to develop improved Camelina varieties for the production of proprietary seed products, and to discover high valuable genetic traits for the agriculture and food industries. Our goals are to efficiently establish a high value seed products business based on developing superior varieties of Camelina for the production of feedstock oils, nutritional oils, and PHA bioplastics, and to license our yield traits to major seed companies for commercialization in major row crops, including corn, soybean and canola. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada.

For more information about the company, please visit www.yield10bio.com, or follow the Company on Twitter, Facebook and LinkedIn.

(YTEN G)

Contacts:
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com

Investor Relations:
Bret Shapiro, (561) 479-8566, brets@coreir.com
Managing Director, CORE IR

Media Inquiries:
Eric Fischgrund, eric@fischtankpr.com
FischTank PR

FAQ

What is Yield10's participation in the 2021 conference?

Yield10's CEO, Oliver Peoples, will present at Maxim Group’s 2021 Inaugural Emerging Growth Virtual Conference from March 17-19, 2021.

How can investors access Yield10's corporate presentation?

Investors can view Yield10's corporate presentation by registering for the conference.

What is Yield10 Bioscience's focus in agriculture?

Yield10 focuses on developing improved Camelina varieties and discovering valuable genetic traits for the agriculture and food industries.

What are Yield10's business goals?

Yield10 aims to establish a high-value seed products business developing superior Camelina varieties for feedstock oils, nutritional oils, and PHA bioplastics.

What major crops does Yield10 target with its traits?

Yield10 targets major row crops, including corn, soybean, and canola, for the commercialization of its yield traits.